Later, this view was expanded to include the potential benefits of counterregulatory humoral molecules with antiproliferative and vasodilative effects, such as natriuretic peptides, and the sodium-glucose cotransporter 2 (SGLT2) inhibitors with a yet unknown mechanism of cardioprotection in HF [2]. This evidence concerns the gene SLC5A2 and hydrops fetalis.